RSSTopics

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

Worsening Choreoathetosis in Huntington’s Disease with Fluoxetine, Lisdexamfetamine, and Melatonin: A Case Report

| July 1, 2018 | 0 Comments

By Clayton J. Hamilton, PharmD; Tysen K. Timmer, BA; Robert C. Munjal, MD; Fernando Cardozo-Pelaez, PhD; and Ian R. McGrane, PharmD Dr. Hamilton is with the Department of Pharmacy, Veteran’s Affairs Montana Medical Center-Fort Harrison, in Helena, Montana. Mr. Timmer is a third-year medical student at the University of Washington School of Medicine in Seattle, […]

Continue Reading

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

Atypical Neuroleptic Malignant Syndrome Precipitated By Clozapine And Quetiapine Overdose: A Diagnostic Challenge

| July 1, 2018 | 0 Comments

By David Choon Liang Teo, MBBS, MRC Psych (UK), FAMS (Psychiatry); Hon Khuan Wong, MBBS; Sheng Neng Tan, MBBS, MMED (Psychiatry), FAMS (Psychiatry) Drs. Teo, Wong and Tan are with the Department of Psychological Medicine, Changi General Hospital, Singapore. Funding: No funding was provided for this article. Disclosures: The authors report no conflicts of interest […]

Continue Reading

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

Ethical Reflections On Offering Patients Accelerated Resolution Therapy (ART)

| July 1, 2018 | 0 Comments

By Edmund G. Howe, MD, JD; Laney Rosenzweig, MS, LMRT; and Amy Shuman, MSW, LICSW, DCSW Dr. Howe is Professor of Psychiatry and Medicine, Uniformed Services University of the Health Sciences, in Bethesda, Maryland. Ms. Rosenzweig is with the Rosenzweig Center for Rapid Recovery in Orlando, Florida. Ms. Shuman is a psychological counselor at the […]

Continue Reading

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

Implementation of the Electronic Columbia-Suicide Severity Rating Scale (eC-SSRS™) Across Four Phase IIIB Clinical Trials in HIV-Infected Individuals (ARIA, STRIIVING, DAWNING and INSPIRING)

| July 1, 2018 | 0 Comments

By Clare Brennan, DPT, MSPH; Hannah Whillis, MS; Choy Man, BS; Brian Wynne, MD; Vani Vannappagari, MBBS, MPH, PhD Dr. Brennan and and Ms. Man are with Clinical Development and Dr. Vannappagari is with Epidemiology and Real World Evidence at ViiV Healthcare in Research Triangle Park, North Carolina. Ms. Whillis was with GlaxoSmithKline, plc, in […]

Continue Reading

Hot Topics in Multiple Sclerosis

Hot Topics in Multiple Sclerosis

| June 1, 2018 | 0 Comments

Click the cover below to access the digital editions of Hot Topics in Multiple Sclerosis! June 2018 March 2018 December 2017 November 2017

Continue Reading

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

Effects of Lisdexamfetamine Dimesylate on Functional Impairment Measured on the Sheehan Disability Scale in Adults With Moderate-to-severe Binge Eating Disorder: Results from Two Randomized, Placebo-controlled Trials

| May 1, 2018 | 0 Comments

by David V. Sheehan, MD, MBA; Maria Gasior, MD, PhD; Susan L. McElroy, MD; Jana Radewonuk, MSc; Barry K. Herman, MD, MMM; and James Hudson, MD, ScD Dr. Sheehan is with the University of South Florida College of Medicine in Tampa, Florida. Drs. Herman and Gasior and Ms. Radewonuk are formerly affiliated with Shire Pharmaceuticals […]

Continue Reading

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

Combination Phentermine–Topiramate Extended Release for the Treatment of Binge Eating Disorder: An Open-Label, Prospective Study

| May 1, 2018 | 0 Comments

Continue Reading